A Phase III, Multi-centre, Randomized Trial to Compare Rivaroxaban With Placebo for the Treatment of Symptomatic Leg Superficial Vein Thrombosis
Phase of Trial: Phase III
Latest Information Update: 12 Dec 2018
Price : $35 *
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Venous thrombosis
- Focus Adverse reactions; Therapeutic Use
- Acronyms RASET
- 03 Dec 2018 Status changed from suspended to completed.
- 18 Dec 2017 Status changed from recruiting to suspended.
- 06 Dec 2016 Planned End Date changed from 1 Mar 2017 to 1 Mar 2018.